T

T Man Pharmaceutical PCL
SET:TMAN

Watchlist Manager
T Man Pharmaceutical PCL
SET:TMAN
Watchlist
Price: 11 THB 1.85%
Market Cap: 4.4B THB

Intrinsic Value

Not Available for TMAN

There is not enough data to reliably calculate the intrinsic value for T Man Pharmaceutical PCL.

Compare TMAN to
Custom
Choose any stock to compare

Fundamental Analysis

TMAN Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

TMAN Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about TMAN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
T Man Pharmaceutical PCL

Balance Sheet Decomposition
T Man Pharmaceutical PCL

Efficiency

Free Cash Flow Analysis
T Man Pharmaceutical PCL

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

TMAN Price Targets Summary
T Man Pharmaceutical PCL

Wall Street analysts forecast TMAN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TMAN is 19.28 THB with a low forecast of 19.09 THB and a high forecast of 19.85 THB.

Lowest
Price Target
19.09 THB
74% Upside
Average
Price Target
19.28 THB
75% Upside
Highest
Price Target
19.85 THB
80% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TMAN is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y